No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
SGMT Sagimet Biosciences
- 4.950
- -0.120-2.37%
Close Dec 20 16:00 ET
- 4.990
- +0.040+0.81%
Post 20:01 ET
159.37MMarket Cap-4.25P/E (TTM)
5.250High4.920Low436.94KVolume4.930Open5.070Pre Close2.20MTurnover2.45%Turnover RatioLossP/E (Static)32.20MShares20.71052wk High0.93P/B88.28MFloat Cap2.39052wk Low--Dividend TTM17.83MShs Float20.710Historical High--Div YieldTTM6.51%Amplitude2.130Historical Low5.036Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
12 Health Care Stocks Moving In Monday's Pre-Market Session
Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
Analysts Offer Insights on Healthcare Companies: Chromadex (CDXC) and Sagimet Biosciences, Inc. Class A (SGMT)
Express News | Sagimet Biosciences Inc : Oppenheimer Initiates Coverage With Outperform Rating; Price Target $30
JMP Securities Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Cuts Target Price to $31
Sagimet Biosciences to Participate in the Piper Sandler 36th Annual Healthcare Conference
Heat List
US
Overall
Symbol
Price
% Chg
No Data